Related Experiment Videos
External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or
Felice Gragnano1, Martin Bøg2, Anders Bo Bojesen3
1Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Caserta, Italy.
Background:
Health economic models, many of which rely on risk equations, often play an important role in informing local healthcare decision making for the management of obesity. Risk equations for predicting cardiovascular outcomes have previously been derived from SELECT trial data. Validation of risk equations in real-world populations can provide confidence in the accuracy and reliability of health economic models.
Objective:
The aim of this study was to validate the predicted outcomes of the novel, SELECT trial-derived cardiovascular risk equations in a real-world UK population with overweight or obesity and established CVD without diabetes using the Clinical Practice Research Datalink (CPRD) database.
Methods:
The SELECT risk equations for acute coronary syndrome (ACS) and stroke were externally validated in a CPRD cohort; records were assessed between 24 October 2008 and 29 March 2021 for patients aged ≥ 45 years with body mass index (BMI) ≥ 27 kg/m2 and established CVD without diabetes. The risk equations were validated both in their original form, and after re-calibration to the CPRD analysis population. Discrimination and calibration were evaluated to assess the predictive performance of the risk equations. The SELECT risk equations, without recalibration, were also compared with published risk equations in terms of their discrimination and calibration.
Results:
The discrimination C-indices at 4 years were 0.65 (95% confidence interval [CI] 0.64-0.65) for ACS and 0.71 (95% CI 0.71-0.71) for stroke. After re-calibration, at 4 years calibration, observed/expected ratio was 1.02 (95% CI 1.00-1.03) for ACS and 0.98 (95% CI 0.96-1.00) for stroke. Prediction accuracy was lower for those with a higher baseline risk of stroke, with over-prediction observed in these patients. For both ACS and stroke, the SELECT risk equations showed better discrimination than Framingham (ACS) (C-index 0.68 vs 0.54) and SMART-REACH (stroke) (C-index 0.74 vs 0.50).
Conclusion:
The recalibrated SELECT risk equations showed acceptable discrimination and good calibration when applied to a real-world population of patients with overweight or obesity and established CVD without diabetes from the CPRD database. These risk equations with calibration also demonstrated better predictive performance compared with published risk equations, supporting their use in health economic evaluations in this patient population.
Related Concept Videos
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...